We are an independent equity research provider that offers innovative and insightful research on selected small/micro-cap US biotech companies. The Replix team, which consists of scientists from pharmaceutical companies, researchers from universities in US/China and other professionals, has considerable investing and trading experience in the healthcare sector. Our goal is to deliver value-added research to enhance the investment process for our clients. We provide actionable and non-consensus analysis through extensive due diligence. If you are interested in our services, please go to: https://www.replixbio.com. Disclaimer - We are not investment advisors, and we do not offer investment advice. The information provided should not be construed as investment advice and should not be considered as a solicitation to buy or sell securities.